Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4272787 | The Journal of Sexual Medicine | 2008 | 11 Pages |
Abstract
These results suggest that short-term treatment with doses of FK506 higher than previously utilized preserves erectile function in the rat CN-injury model. Pretreatment appears to offer no advantage. However, FK506 administration just prior to CN injury and for a short-time post-injury achieves the best functional and structural preservation outcomes. Mulhall JP, Müller A, Donohue JF, Golijanin D, Tal R, Akin-Olugbade Y, Kobylarz K, Cohen-Gould L, Bennett NE, and Scardino P. FK506 and erectile function preservation in the cavernous nerve injury model: Optimal dosing and timing.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
John P. MD, Alexander MD, John F. MD, Dragan MD, Raanan MD, Yemi MD, Keith MS, Leona PhD, Nelson E. MD, Peter MD,